These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7223038)

  • 1. [Tumor-associated antigens and their importance in tumor diagnosis].
    von Kleist S
    Verh Dtsch Ges Inn Med; 1980; 86():503-6. PubMed ID: 7223038
    [No Abstract]   [Full Text] [Related]  

  • 2. [New tumor-associated antigens for diagnosis and follow up of solid tumors].
    Klapdor R
    Schweiz Rundsch Med Prax; 1985 Dec; 74(50):1389-90. PubMed ID: 4081450
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens].
    Shebzukhov IuV; Belousov PV; Khlgatian SV; Sazykin AIu; Kuprash DV; Nedospasov SA
    Mol Gen Mikrobiol Virusol; 2007; (2):3-6. PubMed ID: 17600920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
    Lu H; Goodell V; Disis ML
    J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying tumor antigens in endocrine malignancies.
    Wuttke M; Papewalis C; Jacobs B; Schott M
    Trends Endocrinol Metab; 2009 Apr; 20(3):122-9. PubMed ID: 19269848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor antigens as surrogate markers and targets for therapy and vaccines.
    Dalgleish A; Pandha H
    Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum CA 15.3-ELSA in non-tumor pathology].
    Ruibal A; Genollá J; Rosell M; Moragas G
    Med Clin (Barc); 1987 Mar; 88(11):476. PubMed ID: 3472024
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-associated antigens and the role of antibodies and cellular immunity in cancer. Introduction.
    Vose B
    Immunol Ser; 1994; 61():1-2. PubMed ID: 8011734
    [No Abstract]   [Full Text] [Related]  

  • 10. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can antibodies in serum predict the presence of microscopic tumors?
    Voltz R
    Neurology; 2007 Mar; 68(12):887-8. PubMed ID: 17372122
    [No Abstract]   [Full Text] [Related]  

  • 12. Human tumor cell lysates as a protein source for the detection of cancer antigen-specific humoral immunity.
    Goodell V; Disis ML
    J Immunol Methods; 2005 Apr; 299(1-2):129-38. PubMed ID: 15914197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
    Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor markers].
    Ruibal Morell A
    Med Clin (Barc); 1983 May; 80(17):752-4. PubMed ID: 6621123
    [No Abstract]   [Full Text] [Related]  

  • 15. The reverse proteomics for identification of tumor antigens.
    Lee SY; Jeoung D
    J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. About human tumor antigens to be used in immunotherapy.
    Lucas S; Coulie PG
    Semin Immunol; 2008 Oct; 20(5):301-7. PubMed ID: 18395462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Identification of tumor antigens: strategies and perspectives].
    Zippelius A; Knights A; Tinguely M; Jäger D; Renner C; Knuth A
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1809-12. PubMed ID: 16902905
    [No Abstract]   [Full Text] [Related]  

  • 19. The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy.
    Singh-Jasuja H; Emmerich NP; Rammensee HG
    Cancer Immunol Immunother; 2004 Mar; 53(3):187-95. PubMed ID: 14758508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.
    Singh R; Paterson Y
    Expert Rev Vaccines; 2006 Aug; 5(4):541-52. PubMed ID: 16989634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.